July 07, 2025

Saliva Test May Signal Diabetes-Linked Metabolic Changes

Salivary enzyme levels tied to AMY1 gene copy number may help indicate type 2 diabetes or prediabetes status, new cross-sectional study suggests.

Conexiant

July 07, 2025

Cagrilintide–Semaglutide Yields Weight, A1c Gains

Once-weekly cagrilintide–semaglutide significantly reduced weight and improved glycemic control in adults with type 2 diabetes in the REDEFINE 2 trial.

Conexiant

July 07, 2025

Gene-Starch Interaction Alters Oral Bacteria Balance

A new study found that genetic differences in the AMY1 gene, which affects salivary amylase production, along with dietary starch, influence the types and diversity of bacteria that form in oral biofilms—key players in dental caries and gum disease.

Conexiant

July 02, 2025

Body Fat Percentage Outranks BMI for Mortality

New research shows body fat percentage predicts long-term mortality more accurately than BMI, suggesting a need to revise how body composition is measured in clinical care.

Conexiant

July 02, 2025

Metabolic Syndrome Strongly Linked to Oral Diseases

New research highlights strong associations between metabolic syndrome and several oral diseases—including periodontitis, caries, and peri-implantitis—calling for more longitudinal studies to explore causation and improve patient care.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Lifetime Body Weight Patterns Could Affect Risk of Developing Renal Cell Carcinoma

Investigators explored how weight patterns throughout life may affect an individual’s likelihood of developing renal cell carcinoma.

The ASCO Post

June 27, 2025

CGM Boosts Wound Healing, Lowers A1c: Study

Short-term CGM use improved A1c, wound healing, and reduced ED visits in diabetic foot patients, per data from ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant